1. Phase I trial of topotecan (TT) administered by 24-hour infusion without and with G-CSF;Abbruzzese;Proc. Am. Assoc. Cancer Res.,1993
2. High-dose intensity of CPT-11 administered as single dose every 3 weeks: The Institute Gustav Roussy experience;Abigerges;Proc. Am. Soc. Clin. Oncol.,1993
3. Modulation of 4′-(9-acridinylamino)methanesulfon-m-anisidide-induced topoisomerase II-mediated DNA cleavage by gossypol;Adlakha;Cancer Res.,1989
4. Kinetics of human hematopoietic cells after in vivo administration of granulocyte-macrophage colony stimulating factor;Aglietta;J. Clin. Invest.,1989
5. Synergistic cytotoxicity with combined inhibition of topoisomerase (Topo) I and II;Anzai;Proc. Am. Assoc. Cancer Res.,1992